Korean Market
EXCH
GC Biopharma
★

GC Biopharma discloses corporate governance report, maintains shareholder return policy and plans to address certain non-compliance items

 
MATR
GC Biopharma
★★

GC Biopharma sells entire Curevo stake to Eli Lilly for KRW 460 billion, boosting financial resources for new business and shareholder value

 
PERI
GC Biopharma
★★★

GC Biopharma 2026 Q1 Consolidated Revenue KRW 435.5B, Operating Profit KRW 11.7B… Strong US ALYGLO Sales, Dividend Policy Maintained

 
EXCH
GC Biopharma
★

Minor Increase of 21 Shares by Major Shareholder, Stake Unchanged at 51.41%

 
EXCH
GC Biopharma
★★

Q1 2026 Consolidated Earnings: Operating Profit Up 46%, Net Profit Turns to Black

 
EXCH
GC Biopharma
★★★

Hunterase ICV Receives Marketing Approval in Peru